Webinar
Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-KDR, Angiocept Vector   (CAT#: GTVCR-WQ507MR)

This product GTVCR-WQ507MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting KDR. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_002253.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3791
UniProt ID P35968
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-KDR, Angiocept Vector (GTVCR-WQ507MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1900MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, MEDI-551 Vector Vector MEDI-551
GTVCR-WQ1184MR IVTScrip™ pT7-VEE-mRNA-Anti-VEGFA, Fab-12 variant Y0317 Vector Vector Fab-12 variant Y0317
GTVCR-WQ270MR IVTScrip™ pSP6-VEE-mRNA-Anti-BMP10&GDF2, ACE-041 Vector Vector ACE-041
GTVCR-WQ1512MR IVTScrip™ pT7-VEE-mRNA-Anti-MST1R, IMC RON-8 Vector Vector IMC RON-8
GTVCR-WQ1179MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR, Fab C225 Vector Vector Fab C225
GTVCR-WQ2302MR IVTScrip™ pSP6-VEE-mRNA-Anti-ANGPTL3, REGN 1500 Vector Vector REGN 1500
GTVCR-WQ2064MR IVTScrip™ pT7-VEE-mRNA-Anti-TIGIT, MTIG-7192-A Vector Vector MTIG-7192-A
GTVCR-WQ2560MR IVTScrip™ pT7-VEE-mRNA-Anti-TNF, TNFR55-Ig1 Vector Vector TNFR55-Ig1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.